Abstract:
PROBLEM TO BE SOLVED: To provide polypeptides useful for gene therapy purposes. SOLUTION: A method for constructing a recombinant BAV vector containing a heterologous nucleotide sequence inserted into an insertion site, the method comprising: (a) linking the heterologous nucleotide sequence to sequences which have at least 90% identity to a BAV genome sequence comprising a specific sequence surrounding the insertion site, to form an insertion cassette; wherein the insertion site is located in E3 region; (b) introducing the insertion cassette into a cell, along with a second polynucleotide comprising a sequence having at least 90% identity to a BAV genome comprising a specific nucleotide sequence, wherein whole or a part of the E3 region is deleted; and (c) allowing homologous recombination to occur between the insertion cassette and the polynucleotide to generate the recombinant BAV vector. COPYRIGHT: (C)2007,JPO&INPIT
Abstract:
2129843 9316382 PCTABS00025 The invention relates to a kit for the measurement of anion, cation or zwitterion availability in a medium or for the measurement of free inorganic ions in disrupted cells from plant or animal tissue. The kit comprises ion-exchange material having a measurable ion uptake potential for immobilizing available ions from the medium on the material following contact on the material with the medium or suspension. It also comprises means to remove particulate solids from the material after having contacted the medium with the material. Preferably, the ion-exchange material is cation and/or anion-exchange material in the form of rigid or flexible films, sheets, membranes or the like. The invention also relates to a method for the on-site in situ measurement of anion and/or cation availability in a solid medium and to a method for measuring free organic ions in cells from plant or animal tissue. It also relates to ion-exchange material for immobilizing available ions in soil, sediment or water media and to a cation and/or anion-exchange membrane buried underneath the surface of a soil sample or site, the membrane being in ion-exchange relationship with available ions in the soil. The present invention represents an improvement over the prior art in that it provides means for quickly determining ion availability in a particular media without the necessity of collecting media samples for laboratory testing.
Abstract:
Un primer vector de plásmido de ADN que comprende una primera secuencia de nucleótidos que tiene al menos el 95% de identidad con ORF13 de cepa Imp1010 de PCV-2, para su uso en la reducción de la carga viral de PCV-2 en los ganglios bronquiales y mesentéricos de un cerdo.
Abstract:
Discloses polypeptides having alkanoyl-CoA activity, nucleic acids encoding the same, and methods relating to altering levels or synthesising cannabinoid compounds in an organism, cell or tissue.
Abstract:
The invention provides a delivery system for a biologically active agent comprising a gemini surfactant in admixture with the biologically active agent in a topical formulation for treatment of skin disorders or metabolic diseases. The invention also provides pharmaceutical compositions in topical formulations comprising the delivery system as set out above, in admixture with pharmaceutically acceptable carriers, diluents, excipients, or supplements suitable for application to the skin or mucosal membrane. Methods of preparation and use are also described.
Abstract:
The invention provides a delivery system for a biologically active agent comprising a gemini surfactant in admixture with the biologically active agent in a topical formulation for treatment of skin disorders or metabolic diseases. The invention also provides pharmaceutical compositions in topical formulations comprising the delivery system as set out above, in admixture with pharmaceutically acceptable carriers, diluents, excipients, or supplements suitable for application to the skin or mucosal membrane. Methods of preparation and use are also described.
Abstract:
The present invention relates to chimeric adenovirus capsid proteins comprising a part of or all of an adenovirus capsid protein and a binding partner of a cell-surface binding site on a cell present in gut associated lymphoid tissues (GALT) of a mammal, wherein the chimeric adenovirus capsid protein is capable of binding the cell present in gut associated lymphoid tissues (GALT). In some examples, the adenovirus capsid protein is located on the surface of the adenovirus capsid. The present invention provides adenovirus capsids comprising a chimeric capsid protein. The present invention also provides complexes comprising a chimeric adenovirus capsid protein bound to a cell in GALT. The present invention also provides encapsidation systems and vectors, in particular adenovirus vectors, capable of expressing a chimeric adenovirus capsid protein encompassed within the invention. The present invention also provides viral particles, host cells and compositions comprising such vectors, in particular for use in vaccines, methods of eliciting an immune response and methods for targeted delivery of heterologous proteins, such as antigens, to target cells.
Abstract:
The present invention relates to the identification of bovine adenovirus sequence(s) essential for encapsidation and El transcriptional control regions. The present invention provides adenovirus expression systems, host cells and compositions comprising adenovirus vectors which comprise one or more BAV sequence(s) essential for encapsidation, as well as helper virus which express BAV sequences essential for encapsidation. The present invention also provides helper vectors comprising uBAV sequence essential for encapsidation which is used in a helper virus for propagating recombinant adenovirus. The present invention also provides adenovirus expression systems, host cells and compositions comprising adenovirus vectors which comprise modifications BAV EI transcriptional control regions. The present inventionalso provides methods for making adenovirus vectors comprising BAV sequence(s) essential for encapsidation as well as modifications BAV El transcriptional control regions.
Abstract:
The present invention relates to a process for the aqueous extraction, fractionation and enzymatic treatment of oilseed materials to generate valued products with no significant low value by-product or waste streams. In particular, the fractionation scheme generates a protein-fibre feed ingredient principally for use with ruminant animals and a second dephytinized high protein fraction. The dephytinized high protein fraction has value as feed ingredient for a variety of species of animals.
Abstract:
The present invention relates to a newly discovered Bacillus sp. strain which exhibits pesticidal activity. The supernatant of cultures of this novel isolate are also effective pesticidal agents. Also provided are methods of using the novel strain or supernatant for treatment or prevention of disease in plants or animals.